Association between reproductive factors and urinary estrogens and estrogen metabolites in premenopausal women

Cancer Epidemiology Biomarkers and Prevention

Volumn 21, Issue 6, 2012, Pages 959-968

  Fortner, Renée T ^a,b   Hankinson, Susan E ^a,b,c   Schairer, Catherine ^d   Xu, Xia ^e   Ziegler, Regina G ^d   Eliassen, A Heather ^a,b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATECHOL DERIVATIVE; ESTRADIOL; ESTRIOL; ESTROGEN; ESTRONE;

ADOLESCENT; ADULT; ARTICLE; BREAST CANCER; BREAST FEEDING; CANCER RISK; CHILD; CROSS-SECTIONAL STUDY; ESTROGEN METABOLISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENARCHE; MENSTRUAL CYCLE; METABOLITE; PARITY; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; REPRODUCTION; SCHOOL CHILD; STEROID METABOLISM; URINE LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; ESTROGENS; ESTRONE; FEMALE; HUMANS; MIDDLE AGED; PREMENOPAUSE; RISK ASSESSMENT; RISK FACTORS;

EID: 84862882914     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-12-0171     Document Type: Article

References (35)

1. Kelsey JL, Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993;15:36-47. (Pubitemid 23269069)
2. Key TJ, Verkasalo PK, Banks E. Epidemiology of breast cancer. Lancet Oncol 2001;2:133-40. (Pubitemid 33585924)
3. Kaaks R, Rinaldi S, Key TJ, Berrino F, Peeters PH, Biessy C, et al. Postmenopausal serum androgens, oestrogens and breast cancer risk: The European Prospective Investigation into Cancer and Nutrition. Endocr Relat Cancer 2005;12:1071-82. (Pubitemid 41815798)
4. Key T, Appleby P, Barnes I, Reeves G Endogenous Hormones and Breast Cancer Collaborative Group. Endogenous sex hormones and breast cancer in postmenopausal women: reanalysis of nine prospective studies. J Natl Cancer Inst 2002;94:606-16. (Pubitemid 34498648)
5. Eliassen AH, Missmer SA, Tworoger SS, Spiegelman D, Barbieri RL, Dowsett M, et al. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2006;98:1406-15. (Pubitemid 44530717)
6. Kaaks R, Berrino F, Key T, Rinaldi S, Dossus L, Biessy C, et al. Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005;97:755-65. (Pubitemid 40879595)
7. Walker K, Bratton DJ, Frost C. Premenopausal endogenous oestrogen levels and breast cancer risk: a meta-analysis. Br J Cancer 2011; 105:1451-7.
8. Meilahn EN, De Stavola B, Allen DS, Fentiman I, Bradlow HL, Sepkovic DW, et al. Do urinary oestrogen metabolites predict breast cancer? Guernsey III cohort follow-up. Br J Cancer 1998;78:1250-5. (Pubitemid 28479160)
9. Kabat GC, Chang CJ, Sparano JA, Sepkovie DW, Hu XP, Khalil A, et al. Urinary estrogen metabolites and breast cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 1997;6:505-9. (Pubitemid 27295229)
10. Ursin G, London S, Stanczyk FZ, Gentzschein E, Paganini-Hill A, Ross RK, et al. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 1999;91:1067-72. (Pubitemid 29293046)
11. Joubert A, Van Zyl H, Laurens J, Lottering M. C2- and C4-position 17beta-estradiol metabolites and their relation to breast cancer. Biocell 2009;33:137-40.
12. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354:270-82.
13. Seeger H, Wallwiener D, Kraemer E, Mueck A. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells. Maturitas 2006;54:72-7.
14. Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J. Estradiol 16 alpha-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: a possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 1985;82:6295-9. (Pubitemid 16222871)
15. Bradlow HL, Hershcopf RE, Fishman JF. Oestradiol 16 alpha-hydroxylase: a risk marker for breast cancer. Cancer Surv 1986;5:573-83.
16. Eliassen AH, Spiegelman D, Xu X, Keefer LK, Veenstra TD, Barbieri RL, et al. Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women. Cancer Res 2012;72:696-706.
17. Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ, et al. Estrogen metabolismand risk of breast cancer: a prospective study of the 2:16alpha-hydroxyestrone ratio in premenopausal and postmenopausal women. Epidemiology 2000;11:635-40.
18. Eliassen AH, Missmer SA, Tworoger SS, Hankinson SE. Circulating 2- hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women. Cancer Epidemiol Biomarkers Prev 2008;17:2029-35.
19. Arslan AA, Shore RE, Afanasyeva Y, Koenig KL, Toniolo P, Zeleniuch- Jacquotte A. Circulating estrogen metabolites and risk for breast cancer in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009;18:2273-9.
20. Ziegler RG, Faupel-Badger JM, Sue LY, Fuhrman BJ, Falk RT, Boyd- Morin J, et al. A new approach to measuring estrogen exposure and metabolism in epidemiologic studies. J Steroid Biochem Mol Biol 2010;121:538-45.
21. Xu X, Veenstra TD, Fox SD, Roman JM, Issaq HJ, Falk R, et al. Measuring fifteen endogenous estrogens simultaneously in human urine by high-performance liquid chromatography-mass spectrometry. Anal Chem 2005;77:6646-54. (Pubitemid 41504449)
22. Falk RT, Xu X, Keefer L, Veenstra TD, Ziegler RG. A liquid chromatography- mass spectrometry method for the simultaneous measurement of 15 urinary estrogens and estrogen metabolites: assay reproducibility and interindividual variability. Cancer Epidemiol Biomarkers Prev 2008;17:3411-8.
23. Eliassen AH, Ziegler RG, Rosner B, Veenstra TD,Roman JM, Xu X, et al. Reproducibility of fifteen urinary estrogens and estrogen metabolites over a 2- to 3-year period in premenopausal women. Cancer Epidemiol Biomarkers Prev 2009;18:2860-8.
24. Rosner B. Percentage points for a generalized ESD many-outlier procedure. Technometrics 1983;25:165-72. (Pubitemid 13540616)
25. Van Aswegen CH, Purdy RH, Wittliff JL. Binding of 2-hydroxyestradiol and 4-hydroxyestradiol to estrogen receptors from human breast cancers. J Steroid Biochem 1989;32:485-92. (Pubitemid 19135499)
26. Anstead GM, Carlson KE, Katzenellenbogen JA. The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site. Steroids 1997;62:268-303. (Pubitemid 27114399)
27. Barnea ER, MacLusky NJ, Naftolin F. Kinetics of catechol estrogen-estrogen receptor dissociation: a possible factor underlying differences in catechol estrogen biological activity. Steroids 1983;41: 643-56. (Pubitemid 14242687)
28. Lustig RH, Mobbs CV, Pfaff DW, Fishman J. Temporal actions of 16 alpha-hydroxyestrone in the rat: comparisons of lordosis dynamics with other estrogen metabolites and between sexes. J Steroid Biochem 1989;33:417-21. (Pubitemid 19236143)
29. Telang NT, Suto A, Wong GY, Osborne MP, Bradlow HL. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. J Natl Cancer Inst 1992;84:634-8.
30. Grabrick DM, Vierkant RA, Anderson KE, Cerhan JR, Anderson VE, Seller TA. Association of correlates of endogenous hormonal exposure with breast cancer risk in 426 families (United States). Cancer Causes Control 2002;13:333-41. (Pubitemid 34553514)
31. Titus-Ernstoff L, Longnecker MP, Newcomb PA, Dain B, Greenberg ER, Mittendorf R, et al. Menstrual factors in relation to breast cancer risk. Cancer Epidemiol Biomarkers Prev 1998;7:783-9. (Pubitemid 28420616)
32. Terry KL, Willet WC, Rich-Edwards JW, Hunter DJ, Michels KB. Menstrual cycle characteristics and incidence of premenopausal breast cancer. Cancer Epidemiol Biomarkers Prev 2005;14: 1509-13. (Pubitemid 40807354)
33. Clavel-Chapelon F E3N-EPIC Group. Differential effects of reproductive factors on the risk of pre- and postmenopausal breast cancer. Results from a large cohort of French women. Br J Cancer 2002;86:723-7. (Pubitemid 34250813)
34. Wu AH, Ziegler RG, Pike MC, Nomura AM, West DW, Kolonel LN, et al. Menstrual and reproductive factors and risk of breast cancer in Asian- Americans. Br J Cancer 1996;73:680-6. (Pubitemid 26068877)
35. Faupel-Badger JM, Fuhrman BJ, Xu X, Falk RT, Keefer LK, Veenstra TD, et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol Biomarkers Prev 2010;19:292-300.